US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Articles published by IAVI

News headline image
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development
From IAVI
Via ACCESS Newswire
News headline image
IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
From IAVI
Via Business Wire
News headline image
IAVI Welcomes Marion F. Gruber as Vice President, Public Health and Regulatory Science
From IAVI
Via Business Wire
News headline image
IAVI and the Biomedical Advanced Research and Development Authority Partner to Advance Filovirus Vaccine Candidates
From IAVI
Via Business Wire
News headline image
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
From IAVI
Via Business Wire
News headline image
EDCTP and CEPI Funding Moves IAVI's Lassa fever Vaccine Candidate Into Advanced Clinical Development
From IAVI
Via Business Wire